Theratechnologies EBIT

As of the most recent data (May 2025), THTX shows a EBIT of $190K. That compares with $4.2M in the prior-year period — down 95.4% year over year. That is below the Healthcare sector average of $23B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, THTX's EBIT is now $190K (was $4.2M) — a 95.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Theratechnologies is outperforming or lagging.

The Healthcare sector average EBIT is about $23B. Theratechnologies is at $190K, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how THTX stacks up against individual peers as well.

Tracking THTX's ebit over time shows whether Theratechnologies is scaling, shrinking, or reshaping that part of the business. The current reading is $190K That compares with $4.2M in the prior-year period — down 95.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Theratechnologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $190K) with ownership activity and broader fundamentals.